Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Alendronate, a drug commonly used to treat osteoporosis, ...

Please provide your email address to receive an email when new articles are posted on . Denosumab as a first-line osteoporosis therapy is linked to lower fracture risks than alendronate among ...

Researchers found a small but greater risk of a hip fracture after 2 years of taking a "drug holiday" — stopping therapy — after long-term (≥ 3-year) use of one bisphosphonate, risedronate, versus ...

In postmenopausal women with osteoporosis, prior fracture, and type 2 diabetes, 12 months of romosozumab significantly improved bone strength when combined with alendronate, compared with alendronate ...

It has been known for decades that patients with diabetes have a higher risk of fractures – suggesting a link between the blood sugar regulation and bone quality. More recently, animal studies have ...

Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...

--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...